COVID-19 is not expected to have any direct effect on dermatologicals, with lower value growth than many other consumer health product areas. Nappy (diaper) rash treatments is expected to record the highest current value growth, though this is from a very small base and there was a degree of stockpiling in relation to nappy (diaper) rash treatments. A high birth rate is also contributing to nearly a quarter value growth. The largest product area is topical germicidals/antiseptics and this expect...

Euromonitor International's Dermatologicals in Egypt report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Also Read Link 1 :

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Also Read Link 2 :

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Also Read Link 3 :


Dermatologicals in Egypt
Euromonitor International
November 2020


Degree of stockpiling in nappy (diaper) rash treatments
Competitive product area with little between top three players
High birth rate continues to support strong growth in nappy (diaper) rash treatments
Dermatologicals largely unaffected by COVID-19 and growth continues as normal
Unit price stability returns to the category, supporting higher demand
Prevalence of dermatological conditions remains high due to low hygiene standards

Also Read Link 4 :

Table 1 Sales of Dermatologicals by Category: Value 2015-2020
Table 2 Sales of Dermatologicals by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Dermatologicals: % Value 2016-2020
Table 4 LBN Brand Shares of Dermatologicals: % Value 2017-2020
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2017-2020
Table 6 Forecast Sales of Dermatologicals by Category: Value 2020-2025
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2020-2025

Also Read Link 5 :

COVID-19 impact on consumer health
COVID-19 country impact
Company response
Retailing shift
What next for consumer health?
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 9 Life Expectancy at Birth 2015-2020


[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105